Published in Gene Therapy Weekly, January 25th, 2007
Study 1: Scientists discuss in "Combination of integrin siRNA and irradiation for breast cancer therapy" new findings in cancer. "Up-regulation of integrin alpha(v)beta(3) has been shown to play a key role in tumor angiogenesis and metastasis. In this study, we evaluated the role of integrin alpha(v)beta(3) in breast cancer cell resistance to ionizing irradiation (IR) and tested the anti-tumor efficacy of combining integrin alpha(v) siRNA and IR," investigators in the United States report.
"Colonogenic survival assay, cell proliferation, apoptosis, and cell cycle analysis were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-01-25)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.